{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T23:54:11Z","timestamp":1780444451447,"version":"3.54.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T00:00:00Z","timestamp":1524787200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Esophagus"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s10388-018-0615-y","type":"journal-article","created":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T04:22:00Z","timestamp":1524802920000},"page":"209-216","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Hyponatremia in patients with esophageal cancer treated with chemotherapy including cisplatin"],"prefix":"10.1007","volume":"15","author":[{"given":"Ayako","family":"Shimada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroya","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumasa","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Suda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rieko","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihito","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Kawakubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Kitagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,27]]},"reference":[{"key":"615_CR1","first-page":"989","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Clin. 2015;136:989\u20131243.","journal-title":"Int J Clin"},{"key":"615_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10388-014-0465-1","volume":"12","author":"H Kuwano","year":"2015","unstructured":"Kuwano H, Nishimuea Y, Oyama T, et al. Guidelines for diagnosis and treatment of carcinoma of the esophagus April 2012 edited by the Japanese esophageal society. Esophagus. 2015;12:1\u201330.","journal-title":"Esophagus"},{"key":"615_CR3","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1245\/s10434-011-2049-9","volume":"19","author":"N Ando","year":"2012","unstructured":"Ando N, Kato H, Igaki H, et al. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preopetative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol. 2012;19:68\u201374.","journal-title":"Ann Surg Oncol"},{"key":"615_CR4","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1056\/NEJM199812313392704","volume":"339","author":"DP Kelsen","year":"1998","unstructured":"Kelsen DP, Ginsberg R, Pajak TF, et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med. 1998;339:1979\u201384.","journal-title":"N Engl J Med"},{"key":"615_CR5","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/S0022-5223(97)70147-8","volume":"114","author":"S Law","year":"1997","unstructured":"Law S, Fok M, Chow S, Chu KM, Wong J. Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomized trial. J Thoracic Cardiovasc Surg. 1997;114:210\u20137.","journal-title":"J Thoracic Cardiovasc Surg"},{"key":"615_CR6","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1016\/S0140-6736(02)08651-8","volume":"359","author":"MR Working Group","year":"2002","unstructured":"Working Group MR. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomized controlled trial. Lancet. 2002;359:1727\u201333.","journal-title":"Lancet"},{"key":"615_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa055531","volume":"355","author":"D Cunningham","year":"2006","unstructured":"Cunningham D, Allum WH, Stenning SP, et al. Preoperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355:11\u201320.","journal-title":"N Engl J Med"},{"key":"615_CR8","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1111\/cas.12274","volume":"104","author":"H Hara","year":"2013","unstructured":"Hara H, Tahara M, Diko H, et al. Phase II feasibility study of preoperative chemotherapy with docetaxel, cisplatin and fluorouracil for esophageal squamous cell carcinoma. Cancer Sci. 2013;104:1455\u201360.","journal-title":"Cancer Sci"},{"key":"615_CR9","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1111\/cas.12486","volume":"105","author":"S Hironaka","year":"2014","unstructured":"Hironaka S, Tsubosa Y, Mizusawa J, et al. Phase I\/II trial of 2-weekly docetaxel combined with cisplatin plus fluorouracil in metastatic esophageal cancer. Cancer Sci. 2014;105:1189\u201395.","journal-title":"Cancer Sci"},{"key":"615_CR10","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/sj.ki.5002786","volume":"73","author":"N Pabla","year":"2008","unstructured":"Pabla N, Dong Z. Cisplatin nephrotoxity: mechanisms and renoprotective strategies. Kidney Int. 2008;73:994\u20131007.","journal-title":"Kidney Int"},{"key":"615_CR11","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1007\/s00520-007-0309-9","volume":"15","author":"R Harry","year":"2007","unstructured":"Harry R. Diagnosis and management of hyponatremia in cancer patients. Support Care Cancer. 2007;15:1341\u20137.","journal-title":"Support Care Cancer"},{"key":"615_CR12","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.2169\/internalmedicine.40.1020","volume":"40","author":"K Kagawa","year":"2001","unstructured":"Kagawa K, Fujitaka K, Isobe T, et al. Syndrome of inappropriate secretion of ADH (SIADH) following cisplatin administration in a pulmonary adenocarcinoma patient with a malignant plueral effusion. Intern Med. 2001;40:1020\u20133.","journal-title":"Intern Med"},{"key":"615_CR13","first-page":"48","volume":"34","author":"CY Cheng","year":"2011","unstructured":"Cheng CY, Lin YC, Chen JS, et al. Cisplatin-induced acute hyponatremia leading to a seizure and coma: a case report. Chang Gung Med J. 2011;34:48\u201351.","journal-title":"Chang Gung Med J"},{"key":"615_CR14","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.4103\/0973-1482.146131","volume":"11","author":"E Atas","year":"2015","unstructured":"Atas E, Kesik V, Karaoglu A, et al. Inappropriate antidiuretic syndrome hypersecretion after a single dose of cisplatin. J Cancer Res Ther. 2015;11:1032.","journal-title":"J Cancer Res Ther"},{"key":"615_CR15","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1097\/SMJ.0b013e3181e63682","volume":"103","author":"T Hamdi","year":"2010","unstructured":"Hamdi T, Latta S, Jallad B, et al. Cisplatin-induced renal salt wasting syndrome. South Med J. 2010;103:793\u20139.","journal-title":"South Med J"},{"key":"615_CR16","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3816\/CLC.2003.n.033","volume":"5","author":"AV lyer","year":"2003","unstructured":"lyer AV, Krasnow SH, Dufour DR, et al. Sodium-wasting nephropathy caused by cisplatin in patient with small-cell lung cancer. Clin Lung Cancer. 2003;5:187\u20139.","journal-title":"Clin Lung Cancer"},{"key":"615_CR17","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/00000421-200208000-00005","volume":"25","author":"L Cao","year":"2002","unstructured":"Cao L, Joshi P, Sumoza D. Renal salt-wasting syndrome in a patient with cisplatin-induced hyponatremia: case report. Am J Clin Oncol. 2002;25:344\u20136.","journal-title":"Am J Clin Oncol"},{"key":"615_CR18","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1093\/jjco\/hye085","volume":"31","author":"N Boku","year":"2001","unstructured":"Boku N, Ohtsu A, NagashimaF, et al. Retrospective study of hyponatremia in gastric cancer patients treated with a combination chemotherapy of 5-fluorouracil and cisplatin: a possible warning sign of severe hematological toxities? Jpn J Clin Oncol. 2001;31:382\u20137.","journal-title":"Jpn J Clin Oncol"},{"key":"615_CR19","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1634\/theoncologist.2011-0400","volume":"17","author":"JJ Castillo","year":"2012","unstructured":"Castillo JJ, Marc V, Eric J, et al. Diagnosis and management of hyponatremia in cancer patients. Oncologist. 2012;17:756 \u2013 65.","journal-title":"Oncologist"},{"key":"615_CR20","volume-title":"TNM classification of malignant tumors","author":"UCC","year":"2009","unstructured":"UCC (2009) TNM classification of malignant tumors. Wiley, Weinheim"},{"key":"615_CR21","doi-asserted-by":"publisher","first-page":"164","DOI":"10.7326\/0003-4819-102-2-164","volume":"102","author":"RJ Anderson","year":"1985","unstructured":"Anderson RJ, Chung HM, Kluge R, et al. (1985) Hyponatremia: a prospective analysis of its epidemiology and the pathogenetic role of vasopressin. Ann Intern Med. 102:164\u20138.","journal-title":"Ann Intern Med"},{"key":"615_CR22","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1159\/000324653","volume":"119","author":"P Esposto","year":"2011","unstructured":"Esposto P, Piotti G, Biansina S, et al. The syndrome of inappropriate antidiuresis: pathophysiology, clinical management and new therapeutic options. Nephron Clin Pract. 2011;119:62\u201373.","journal-title":"Nephron Clin Pract"},{"key":"615_CR23","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/mpo.2950120219","volume":"12","author":"J Kurtzberg","year":"1984","unstructured":"Kurtzberg J, Dennis VW, Kinney TR. Cisplatinum-induced renal salt wasting. Med Pediatric Oncol. 1984;12:150\u20134.","journal-title":"Med Pediatric Oncol"},{"key":"615_CR24","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/00000421-200208000-00005","volume":"25","author":"L Cao","year":"2002","unstructured":"Cao L, Joshi P, Sumoza D. Renal salt-wasting syndrome in a patient with cisplatin-induced hyponatremia. Am J Clin Oncol. 2002;25:344\u20136.","journal-title":"Am J Clin Oncol"}],"container-title":["Esophagus"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10388-018-0615-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10388-018-0615-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10388-018-0615-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T07:10:56Z","timestamp":1556349056000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10388-018-0615-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,27]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["615"],"URL":"https:\/\/doi.org\/10.1007\/s10388-018-0615-y","relation":{},"ISSN":["1612-9059","1612-9067"],"issn-type":[{"value":"1612-9059","type":"print"},{"value":"1612-9067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,27]]},"assertion":[{"value":"31 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}},{"value":"Author Ayako Shimada, Hiroya Takeuchi, Kazumasa Fukuda, Koichi Suda, Rieko Nakamura, Norihito Wada, and Hirofumi Kawakubo declare that they have no conflict of interest. Author Yuko Kitagawa received designated donation from Sanofi K.K., Kyowa Hakko Kirin Co., Ltd, and Yakult Honsha Co., Ltd.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}